Anthropic walks back policy restricting AI researchers using Claude
Anthropic reversed a policy that critics said could have 'sabotaged' AI researchers using Claude. Simon Willison is reporting on the policy change, which appears to have restricted how AI researchers could use Claude for their work. The reversal signals responsiveness to researcher community pushback on usage policies.
Related guides (4)
Related events (8)
Andrew Ng commentary on Anthropic's Claude Fable 5 restrictions and U.S. export controls on frontier AI models
Andrew Ng's The Batch editorial covers two significant recent events: Anthropic releasing Claude Fable 5 (a guardrailed version of Claude Mythos 5) with terms restricting use for competing LLM development, and the U.S. Government applying export controls via the Commerce Department that forced Anthropic to disable global access to Fable. Ng argues these moves demonstrate how private companies and governments can suddenly restrict AI access, accelerating global interest in AI sovereignty and open-source alternatives. The piece also notes that independent evaluators struggled to assess Claude Fable 5 due to model routing behavior and Anthropic's new data retention policy.
U.S. Department of War bans Anthropic, contracts OpenAI for classified AI systems after standoff over safety restrictions
The U.S. Department of War designated Anthropic a supply-chain risk to national security after the company refused to remove restrictions on Claude's use for domestic surveillance and autonomous weapons, effectively banning it from military and contractor use. OpenAI signed a contract allowing use of its models 'for all lawful purposes' with ambiguous carve-outs for surveillance and autonomous weapons, which Altman later called rushed and renegotiated. The standoff culminated in a Trump Truth Social post threatening civil and criminal consequences against Anthropic, followed by Hegseth's formal designation. The episode marks a significant precedent: the supply-chain risk designation, previously applied only to foreign companies, was used against a U.S. AI lab over its own usage policies.
The AI Ad-Hoc Prior Restraint Era Begins
Zvi Mowshowitz reports that the White House has ordered Anthropic to halt expansion of access to Mythos, and is considering a broader policy shift to a prior restraint regime requiring government approval before releasing highly capable AI models. This would represent a major reversal of current U.S. frontier AI policy. The commentary analyzes the implications of such a regulatory posture for the AI industry.
Andrew Ng argues Anthropic's usage restrictions and U.S. export controls on frontier AI accelerate push for open alternatives
Andrew Ng's editorial in The Batch analyzes two recent events: Anthropic restricting use of its 'Fable 5' model for LLM research (including initially degrading outputs silently for detected researchers), and the U.S. Commerce Department imposing export controls requiring licenses for foreign nationals to access the model. Ng argues both moves demonstrate how private companies and governments can unilaterally cut off AI access, accelerating AI sovereignty efforts globally and increasing incentives to invest in open-source alternatives. He draws parallels to semiconductor and rare earth supply chain dynamics, warning that fear-based safety marketing by AI labs invites exactly the government overreach that disrupts the ecosystem.
Anthropic Updates Usage Policy: Agentic Use, Cybersecurity, and Political Content
Anthropic has revised its Usage Policy effective September 15, 2025, with changes addressing agentic and cybersecurity risks, political content restrictions, law enforcement use clarity, and high-risk consumer-facing requirements. New sections explicitly prohibit malicious computer/network compromise activities while supporting legitimate security research, responding to the rapid expansion of agentic tools like Claude Code and Computer Use. The policy also narrows its previous blanket ban on political content to focus specifically on deceptive or voter-targeting uses, enabling legitimate civic and policy research. High-risk safeguards (human-in-the-loop, AI disclosure) are clarified to apply only to consumer-facing outputs, not B2B interactions.
Anthropic Partners with Allen Institute and HHMI to Deploy Claude in Frontier Life Sciences Research
Anthropic has announced flagship partnerships with the Allen Institute and Howard Hughes Medical Institute (HHMI) to embed Claude into active scientific workflows at both institutions. HHMI's collaboration, anchored at Janelia Research Campus, focuses on developing specialized AI agents integrated with scientific instruments and analysis pipelines. The Allen Institute partnership targets multi-agent systems for multi-modal biological data analysis, including multi-omic integration, knowledge graph management, and experimental design coordination. Both partnerships emphasize interpretability, researcher autonomy, and transparency, with the stated goal of compressing months of manual analysis while keeping human scientists in control of scientific direction.
Anthropic Publishes Updated Claude's Constitution (Jan 2026 Revision)
Anthropic has released an updated version of Claude's Constitution, the explicit set of principles governing Claude's values and behavior under the Constitutional AI (CAI) framework. The post explains how CAI uses AI-generated feedback rather than large-scale human feedback to train models toward helpful, honest, and harmless behavior, with the constitution guiding both self-critique/revision and reinforcement learning phases. The constitution draws from sources including the UN Declaration of Human Rights, DeepMind's Sparrow Principles, Apple's terms of service, and Anthropic's own safety research. Anthropic frames the constitution as a work-in-progress and invites broader participation in designing AI constitutions.
How scientists are using Claude to accelerate research and discovery
Anthropic describes how researchers are deploying Claude-powered systems across scientific workflows, highlighting three case studies: Biomni (a Stanford agentic platform integrating hundreds of biomedical tools), the Cheeseman Lab (automating large-scale gene knockout experiment interpretation), and others. The piece details Claude for Life Sciences and the AI for Science program, which provides free API credits to high-impact research projects. Specific benchmarks cited include compressing months-long GWAS analyses to 20 minutes and analyzing 336,000 single-cell datasets to identify novel transcription factors.